/
Nephrology
227Diseases↗
820Pipeline Programs↗
978Active Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
4,307
clinical trials
Completed2,308 · 54%
Recruiting511 · 12%
Unknown status477 · 11%
Terminated368 · 9%
Not yet recruiting270 · 6%
Active, not recruiting167 · 4%
Other206 · 5%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
Landscape
Diseases
Kidney Disease
Most programs158
Programs
318
Trials
16
Recruiting
Pre
20
P1
4
P2
5
P3
3
Appr
74
Most programs:
Novartis
NovartisChronic Kidney Disease
Most trials108
Programs
221
Trials
85
Recruiting
Pre
60
P1
7
P2
15
P3
18
Appr
72
Most programs:
Sanofi
SanofiNephropathy
Highest activity105
Programs
146
Trials
8
Recruiting
Pre
14
P1
2
P2
2
P3
4
Appr
14
Most programs:Novartis
NovartisAcute Kidney Injury
856 programs99 trialsApproved
Lupus Nephritis
239 programs70 trialsApproved
Iga Nephropathy
139 programs54 trialsApproved
CKD
2 programs86 trialsPhase 3
Membranous Nephropathy
225 programs37 trialsApproved
Nephrotic Syndrome
120 programs25 trialsApproved
Renal Impairment
215 programs30 trialsApproved
Diabetic Nephropathy
125 programs19 trialsApproved
Primary Membranous Nephropathy
26 programs27 trialsPhase 2
End-Stage Renal Disease
8 programs21 trialsApproved
Renal Insufficiency
15 programs13 trialsApproved
Renal Disease
11 program27 trialsPhase 2
Kidney Stone
3 programs21 trialsPhase 3
Polycystic Kidney Disease
3 programs20 trialsApproved
Primary Iga Nephropathy
21 program20 trialsPhase 3
Autosomal Dominant Polycystic Kidney Disease
26 programs14 trialsApproved
Glomerulonephritis
4 programs16 trialsApproved
Cystic Kidney Disease
0 programs20 trials
Renal Colic
11 programs8 trialsApproved
End-Stage Kidney Disease
31 program18 trialsPhase 1
Immunoglobulin a Nephropathy
11 program18 trialsPhase 3
Chronic Kidney Disease (CKD)
2 programs16 trialsPhase 3
Kidney Failure
10 programs6 trialsApproved
Alport Syndrome
9 programs7 trialsApproved
Kidney Stones
15 programs11 trialsApproved
Focal Segmental Glomerulosclerosis
26 programs9 trialsApproved
Glomerulopathy
0 programs15 trials
Showing top 30 diseases by activity. 197 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)